Sepsis

Blood culture contamination remains a persistent challenge in healthcare, impacting patient care and outcomes, and driving up costs. As awareness grows, blood culture kitting has emerged as a practical solution to improve sample collection by standardizing supplies, simplifying decision-making, and reducing waste.

A recent survey by bioMérieux and The UK Sepsis Trust found that while 95% of clinicians identify sepsis as a serious condition, 66% agree there is sometimes a delay in diagnosis in the hospital where they work. 

A recent retrospective study examining sepsis treatment in patients with and without pulmonary arterial hypertension (PAH) reveals critical insights for clinical practice.

Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!

Delve into the critical challenges of sepsis management in resource-limited settings with Professor Machado's insightful interview.

A study shows source-specific antibiotic order sets in emergency care improve empiric treatment decisions for sepsis and support timely patient management.

A study from The University of Manchester highlights how socioeconomic factors increase mortality risk in non-COVID sepsis, stressing targeted prevention.

A new study with the UK Sepsis Trust explores barriers to sepsis care bundle adherence in Europe and offers insights to improve sepsis management strategies.

A clinical trial in West Africa tests whether intrapartum azithromycin reduces neonatal sepsis and mortality, with additional evaluation of infection and fever rates.

The SepSIGN trial aims to validate biomarkers that help predict early clinical worsening in adults admitted to the ED with suspected or confirmed infection.

Sepsis linked to opioid use is an overlooked crisis driving hospitalizations and harm, with experts urging strategies to address this growing public health issue.

The Surviving Sepsis Campaign infographic highlights updated global guidelines on antibiotic timing, vasoactive agents, and septic shock care.

Balancing timely sepsis treatment with AKI risk, experts highlight how early biomarker assessment can guide safer, more effective antimicrobial use.

September is Sepsis Awareness Month, with resources and tools to help individuals and healthcare teams raise awareness and improve patient outcomes.

A systematic review shows COVID-19 ICU patients often meet sepsis criteria, highlighting the need for targeted treatments and policies for future pandemics.

A podcast explores how new CAP guidelines view procalcitonin use alongside clinical judgment to guide antibiotic decisions in sepsis and respiratory care.